Business News›Industry›Healthcare/Biotech›Healthcare›Bharat Biotech’s dossier under review for Covaxin Emergency Use Listing: WHO
Bharat Biotech’s dossier under review for Covaxin Emergency Use Listing: WHO
Officials of the World Health Organisation (WHO) had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker's dossier for Emergency Use Listing (EUL) of Covaxin is under review by the technical experts for consideration, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said on July 19.
164views
Read more on